Oncology Institute (DFPH) Non-Current Deferred Tax Liability (2020 - 2025)

Oncology Institute (DFPH) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $7.8 million the latest figure, recorded in Q4 2025.

• Non-Current Deferred Tax Liability for Q4 2025 came in at $7.8 million, up 24171.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.8 million (up 24171.88% YoY), and the FY2025 annual result was $7.8 million, up 24171.88% from the prior year.
• Non-Current Deferred Tax Liability was $7.8 million for Q4 2025 at Oncology Institute, up from $32000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $10.2 million in Q4 2023 and troughed at $32000.0 in Q1 2024.
• Average Non-Current Deferred Tax Liability over 5 years is $1.9 million, with a median of $158000.0 recorded in 2023.
• Year-over-year, Non-Current Deferred Tax Liability slumped 99.69% in 2024 and jumped 24171.88% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $371000.0 in 2021, then surged by 2244.47% to $8.7 million in 2022, then rose by 17.38% to $10.2 million in 2023, then plunged by 99.69% to $32000.0 in 2024, then surged by 24171.88% to $7.8 million in 2025.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $7.8 million in Q4 2025, $32000.0 in Q1 2025, and $32000.0 in Q4 2024.